Industrials · Guided Missiles & Space Vehicles & Parts

RKLB Rocket Lab Corp SEC Filings & Insider Trading Activity 2026

company
CIK 1819994106 filings

RKLB at a glance

Rocket Lab Corp (RKLB, SEC CIK 1819994) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and Form 4 insider filings as recently as November 18, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Rocket Lab Corp (RKLB) reported revenue of $601.8 million (up 38.0% from FY2024) and a net loss of $198.2 million. Diluted EPS was -$0.37.
  • As of September 30, 2026, 38 institutional investment managers tracked by SignalX reported holding Rocket Lab Corp (RKLB) shares worth $12.1 billion in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Spice Adam C. on November 2, 2026 of 33,681 shares at $53.29 per share.
  • In the last 90 days, RKLB insiders reported 0 open-market purchases ($0) and 35 open-market sales ($34.9M) on Form 4, a net sale of $34.9M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$601.8M
+38.0% vs prior year
Insiders · 90 days
0 buys · 35 sells
Net −$34.9M
13F holders
38 funds
$12.1B · −4 vs prior quarter
Latest 8-K
Nov 9, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Q3 revenue $267.8M, up 73% YoY from $155.1M, led by Space Systems at $214.8M, up 88%
  • Gross margin 33.6% vs 37.0% YoY; operating margin (29.6)% vs (38.0)%; net margin (29.7)% vs (11.7)%
  • Launch Services revenue $53.1M, up 30%; Space Systems largest segment, with $143.4M cost of revenue
  • Cash and equivalents $4.4B plus marketable securities $256.2M; operating cash outflow $127.3M through nine months
  • Neutron inaugural launch delayed to 2027; Iridium acquisition expected to close in 2027, requiring over $3.0B cash

Risk Factors

  • Neutron launch schedule risk: first-stage composite manufacturing issue caused further delay during fourth quarter of 2026
  • Neutron qualification failure: Stage 1 tank ruptured during hydrostatic testing on January 21, 2026
  • Revenue concentration risk: unsustainable product and services order rates could adversely affect financial performance
  • Market risk: cyclical launch and spacecraft markets may impair customer-demand forecasting
  • Competitive technology risk: failure to commercialize new technologies before competitors could materially harm results

AI summary of the RKLB 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 9, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 results for quarter ended September 30, 2026
  • Press release contains Rocket Lab’s financial figures and management commentary

Item EX-99.1: Item EX-99.1

  • Q3 revenue $267.8M, up 73% year-over-year, with gross profit $90.1M and GAAP operating loss $79.2M
  • Backlog reached approximately $3.6B, up 52% sequentially, including approximately $1B of new launch contracts
Filed Oct 14, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Rocket Lab provided a Neutron rocket development update through a press release and investor presentation
  • Neutron progress is material to Rocket Lab’s launch strategy and future revenue potential

Item 8.01: Other Events

  • Neutron’s first launch delayed from 2026 into 2027
  • Schedule shift reflects ongoing development and process improvements

Item EX-99.1: Item EX-99.1

  • Neutron inaugural launch target moved to 2027, signaling development or testing delays versus prior expectations
  • Schedule shift postpones Rocket Lab’s medium-lift and reusable-launch capabilities, potentially delaying related revenue opportunities
Filed Sep 15, 2026Full analysis →

Item 7.01: Regulation FD Disclosure

  • Financing updates for Rocket Lab’s pending Iridium acquisition
  • Acquisition funding structure potentially affecting leverage, dilution and transaction certainty

Item 8.01: Other Events

  • Iridium lenders consented to the acquisition, preventing a change-of-control trigger and allowing $1.775 billion of term loans to remain outstanding
  • Post-closing term-loan pricing increases to SOFR plus 2.50%-3.00%, or base rate plus 1.50%-2.00%, based on credit ratings

Item EX-99.1: Item EX-99.1

  • $1.944B ATM completed through 29.3M shares, materially funding Iridium’s cash consideration but diluting existing Rocket Lab shareholders
  • Iridium acquisition expected mid-2027, still contingent on regulatory approvals and other closing conditions

AI summaries of RKLB 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for RKLB

Don't miss the next RKLB filing

  • Alerts as it files. A push when RKLB files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut RKLB, by share count.
  • Ask anything. An AI agent that reads every RKLB filing and answers with sources.

RKLB alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Ricupati AgostinoANov 17, 2026-
Spice Adam C.SellNov 2, 2026$53.29
Armagno NinaSellNov 2, 2026$51.31
Spice Adam C.SellNov 2, 2026$51.28
Armagno NinaSellNov 2, 2026$54.34
Armagno NinaSellNov 2, 2026$53.55
Armagno NinaSellNov 2, 2026$55.01
Armagno NinaSellNov 2, 2026$52.63

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$436.2M$601.8M
Gross Profit-$116.1M$207.2M
Operating Income--$189.8M-$228.8M
Net Income--$190.2M-$198.2M
Gross Margin-26.6%34.4%
Op. Margin--43.5%-38.0%
Net Margin--43.6%-32.9%
Balance Sheet
Total Assets-$1.2B$2.3B
Equity$554.5M$382.5M$1.7B
ROE--49.7%-11.5%
Per Share
EPS-$-0.38$-0.37
Cash Flow
Operating CF--$48.9M-$165.5M
CapEx$54.7M$67.1M$156.3M

Source: XBRL data in Rocket Lab Corp (RKLB)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate RKLB share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
RKLB shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202638$12.06B
Q2 202642$18.16B
Q1 202640$9.80B
Q4 202539$11.06B
Q3 202538$7.88B
Q2 202531$5.33B
Position changes: Q2 2026 → Q3 2026
Top Sellers

Source: 13F-HR filings on SEC EDGAR (aggregated from 228 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

RKLB filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 18, 2026--
10-QNov 9, 2026Analysis
8-KNov 9, 2026Analysis-
4Nov 3, 2026--
4Nov 3, 2026--
8-KOct 14, 2026Analysis-
4Oct 2, 2026--
8-KSep 15, 2026Analysis-
4Sep 4, 2026--
4Sep 2, 2026--
4Aug 28, 2026--
4Aug 28, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 26, 2026--
4Aug 18, 2026--
8-KAug 13, 2026Analysis-
8-KAug 13, 2026Analysis-
8-KAug 10, 2026Analysis-
10-QAug 10, 2026-
4Jul 8, 2026--
8-KJun 29, 2026Analysis-
4Jun 18, 2026--

Related Industrials companies

All Industrials →

RKLB SEC filings: frequently asked questions

Are RKLB insiders buying or selling?

In the last 90 days, Rocket Lab Corp (RKLB) officers, directors and 10% owners reported no open-market purchases and 35 open-market sales worth $34.9 million by 6 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold RKLB stock?

As of September 30, 2026, the largest Rocket Lab Corp (RKLB) holders among the 13F filers tracked by SignalX were BlackRock ($2.9 billion), Vanguard Portfolio Management LLC ($2.0 billion), Vanguard Capital Management LLC ($1.8 billion), Invesco Ltd ($1.2 billion), State Street Corp ($1.1 billion). 13F-HR reports are filed up to 45 days after each quarter ends.

What was RKLB's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Rocket Lab Corp (RKLB) reported revenue of $601.8 million (up 38.0% from FY2024) and a net loss of $198.2 million. Diluted EPS was -$0.37. The figures come from the XBRL data in the 10-K.

What did RKLB report in its latest 8-K?

Rocket Lab Corp (RKLB) filed an 8-K on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 2026 results for quarter ended September 30, 2026.

What are the latest RKLB SEC filings?

Rocket Lab Corp (RKLB) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and a Form 4 insider filing on November 18, 2026.

What is RKLB's SEC CIK number?

Rocket Lab Corp (RKLB)'s SEC Central Index Key (CIK) is 1819994. EDGAR lists every RKLB filing under that number.

Ask anything about RKLB

The research agent reads RKLB's filings, financials, insider trades and 13F holders, then answers with sources.